![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 14, 2022 9:25:29 AM
Yes, when leronlimab is use , its work..but FDA decided to sabotage CD12 , company applied according to Dr Lalezari for 4 weeks treatment for severe and critical patients , but FDA refused to approve it , and cut treatment to 2 weeks.
Why was that ,??
Drug is use for many years already weekly in patients, without stopping , and without one serious side effects..
why will anyone limit to 2 doses patients dying on the ventilators and ECMO..
It was very difficult to find explanation , but now we know ..
Vaccination must receive EUA and be mandated , and for that no good drug could be approve...
So not one good drug is approved for hospitalized patients , and about 1 million American died by now,
in CD12 , critical patients , at 14 days when leronlimab was still in the system , mortality benefit above all the toxic SOC drugs was 82% ..
82% mortality benefit ABOVE all the SOC drugs ..
Was FDA excited about it , no...
They needed to fine something not to give EUA ...
So it was ....ONLY 62 patients...only subgroup etc...
ONLY 62 ???
We all know , the less patients in the group the more difficult to prove efficacy..
They were not even curious how to help this company with great drug to save lives... no interest at all.
Below again Veritas video with FDA executive , how and why they need to mandate vaccines..
" it bring recurrent revenue in billions to the company every year "
and
" hundreds of millions company is giving to the FDA.."
" vaccine must be mandate.."
Even for 6 months old and up , dont we see side effects and a very little efficacy in young ?
" yes, and we dont know what will happen long time after the vaccine " .." but it is covid , so it will be mandate "
I listen to this video , every few days , and each time I have a hard time to believe it...
https://www.projectveritas.com/news/fda-executive-officer-on-hidden-camera-reveals-future-covid-policy-biden/
And below evaluation of some side effects of the vaccine , especially in the young one..
https://www.theblaze.com/op-ed/horowitz-vaers-myocarditis-already-47-of-2021-in-just-first-2-months-of-2022
But is any of the side effects giving pause to Dr Fauci , CDC , FDA..
No ,
Because as FDA executive said ..
"Company will have recurrent revenue in billions every year when vaccine is mandated ", " it will be done "
all IMO.
Recent CYDY News
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM